NDC 0074-2625 Mavyret
Glecaprevir And Pibrentasvir Tablet, Film Coated Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0074 - Abbvie Inc.
- 0074-2625 - Mavyret
Product Characteristics
Product Packages
NDC Code 0074-2625-01
Package Description: 1 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
Price per Unit: $152.56411 per EA
NDC Code 0074-2625-28
Package Description: 4 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
Price per Unit: $152.56411 per EA
NDC Code 0074-2625-56
Package Description: 2 CARTON in 1 CARTON / 4 CARTON in 1 CARTON / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
NDC Code 0074-2625-84
Package Description: 84 TABLET, FILM COATED in 1 BOTTLE
Price per Unit: $152.56411 per EA
Product Details
What is NDC 0074-2625?
What are the uses for Mavyret?
What are Mavyret Active Ingredients?
Which are Mavyret UNII Codes?
The UNII codes for the active ingredients in this product are:
- PIBRENTASVIR (UNII: 2WU922TK3L)
- PIBRENTASVIR (UNII: 2WU922TK3L) (Active Moiety)
- GLECAPREVIR (UNII: K6BUU8J72P)
- GLECAPREVIR (UNII: K6BUU8J72P) (Active Moiety)
Which are Mavyret Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- VITAMIN E POLYETHYLENE GLYCOL SUCCINATE (UNII: O03S90U1F2)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)
- HYPROMELLOSE 2910 (15 MPA.S) (UNII: 36SFW2JZ0W)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- COPOVIDONE K25-31 (UNII: D9C330MD8B)
- PROPYLENE GLYCOL MONOCAPRYLATE (UNII: RT9P9S09QI)
What is the NDC to RxNorm Crosswalk for Mavyret?
- RxCUI: 1940703 - glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet
- RxCUI: 1940709 - Mavyret 100 MG / 40 MG Oral Tablet
- RxCUI: 1940709 - glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]
- RxCUI: 1940709 - Mavyret (glecaprevir 100 MG / pibrentasvir 40 MG) Oral Tablet
- RxCUI: 2557906 - glecaprevir 50 MG / pibrentasvir 20 MG per packet Oral Pellet
Which are the Pharmacologic Classes for Mavyret?
- Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
- Breast Cancer Resistance Protein Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 1A2 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
- HCV NS3/4A Protease Inhibitors - [MoA] (Mechanism of Action)
- Hepatitis C Virus NS3/4A Protease Inhibitor - [EPC] (Established Pharmacologic Class)
- Hepatitis C Virus NS5A Inhibitor - [EPC] (Established Pharmacologic Class)
- Organic Anion Transporting Polypeptide 1B1 Inhibitors - [MoA] (Mechanism of Action)
- Organic Anion Transporting Polypeptide 1B3 Inhibitors - [MoA] (Mechanism of Action)
- P-Glycoprotein Inhibitors - [MoA] (Mechanism of Action)
- UGT1A1 Inhibitors - [MoA] (Mechanism of Action)
* Please review the disclaimer below.
Patient Education
Glecaprevir and Pibrentasvir
The combination of glecaprevir and pibrentasvir is used to treat certain types of chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in adults and children 3 years of age and older. It is also used to treat certain types of chronic hepatitis C infection in adults and children 3 years of age and older who have already received another medication to treat their hepatitis C infection. Glecaprevir is in a class of medications called HCV NS3/4A protease inhibitors. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Pibrentasvir is in a class of medications called HCV NS5A inhibitors. It works by stopping the virus that causes hepatitis C to spread inside the body.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".